Get started
TransMedics Group, Inc.TransMedics Group, Inc.TransMedics Group, Inc.

TransMedics Group, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with TransMedics Group, Inc.



Key facts today


TD Cowen maintained its price target of $120 per share for TransMedics Group, Inc. (TMDX) in a recent research note; no change to the firm’s published target was reported in the summary provided. 1
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪3.12 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
22.63
Basic EPS (TTM)
4.43 USD
Net income (FY)
‪190.29 M‬ USD
Revenue (FY)
‪605.49 M‬ USD
Shares float
‪33.34 M‬
Beta (1Y)
1.67

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
898
Change (1Y)
+170+23.35%
Revenue / Employee (1Y)
‪674.27 K‬ USD
Net income / Employee (1Y)
‪211.91 K‬ USD

Company info


Sector
Health Technology
Industry
Medical Specialties
CEO
Waleed H. Hassanein
Website
transmedics.com
Headquarters
Andover
Founded
1998
IPO date
May 2, 2019
ISIN
US89377M1099
CUSIP
89377M109
FIGI
BBG00NZ6J685
Identifiers
ISIN US89377M1099
CFI code
ESVUFR
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


— YTM
Maturity dateJun 1, 2028
Coupon1.50% (Fixed)

See all TMDX bonds 

ETFs holding the stock


IJR
iShares Core S&P Small-Cap ETF
Weight0.17%
Market value‪189.65 M‬
IWM
iShares Russell 2000 Index Fund
Weight0.10%
Market value‪78.97 M‬
VBK
Vanguard Morningstar Small-Cap Growth ETF
Weight0.07%
Market value‪33.35 M‬
XSMO
Invesco S&P SmallCap Momentum ETF
Weight1.01%
Market value‪30.50 M‬
VXF
Vanguard Extended Market ETF
Weight0.03%
Market value‪30.44 M‬
IJT
iShares S&P SmallCap 600 Growth ETF
Weight0.36%
Market value‪29.45 M‬
IWO
iShares Russell 2000 Growth Fund
Weight0.20%
Market value‪28.71 M‬
SPSM
State Street SPDR Portfolio S&P 600 Small Cap ETF
Weight0.17%
Market value‪28.59 M‬
ULTY
YieldMax Ultra Option Income Strategy ETF
Weight3.47%
Market value‪25.96 M‬
PSC
Principal U.S. Small-Cap ETF
Weight0.66%
Market value‪18.06 M‬
SLYG
State Street SPDR S&P 600 Small Cap Growth ETF
Weight0.36%
Market value‪18.05 M‬

Explore more ETFs 

Frequently asked questions


The current price of TMDX is 88.27 USD — it has increased by 3.45% in the past 24 hours. Watch TransMedics Group, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TransMedics Group, Inc. stocks are traded under the ticker TMDX.
TMDX stock has fallen by −2.09% compared to the previous week, the month change is a 24.39% rise, over the last year TransMedics Group, Inc. has showed a −15.41% decrease.
We've gathered analysts' opinions on TransMedics Group, Inc. future price: according to them, TMDX price has a max estimate of 125.00 USD and a min estimate of 65.00 USD. Watch TMDX chart and read a more detailed TransMedics Group, Inc. stock forecast: see what analysts think of TransMedics Group, Inc. and suggest that you do with its stocks.
TMDX reached its all-time high on Aug 23, 2024 with the price of 177.37 USD, and its all-time low was 10.00 USD and was reached on Feb 24, 2022. View more price dynamics on TMDX chart.
See other stocks reaching their highest and lowest prices.
TMDX stock is 4.45% volatile and has beta coefficient of 1.67. Track TransMedics Group, Inc. stock price on the chart and check out the list of the most volatile stocks — is TransMedics Group, Inc. there?
Today TransMedics Group, Inc. has the market capitalization of ‪3.12 B‬, it has decreased by −10.82% over the last week.
Yes, you can track TransMedics Group, Inc. financials in yearly and quarterly reports right on TradingView.
TransMedics Group, Inc. is going to release the next earnings report on Nov 4, 2026. Keep track of upcoming events with our Earnings Calendar.
TMDX earnings for the last quarter are 0.44 USD per share, whereas the estimation was 0.50 USD resulting in a −11.20% surprise. The estimated earnings for the next quarter are 0.30 USD per share. See more details about TransMedics Group, Inc. earnings.
TransMedics Group, Inc. revenue for the last quarter amounts to ‪189.95 M‬ USD, despite the estimated figure of ‪184.00 M‬ USD. In the next quarter, revenue is expected to reach ‪177.03 M‬ USD.
TMDX net income for the last quarter is ‪14.68 M‬ USD, while the quarter before that showed ‪7.32 M‬ USD of net income which accounts for 0.00% change. Track more TransMedics Group, Inc. financial stats to get the full picture.
No, TMDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 9, 2026, the company has 898 employees. See our rating of the largest employees — is TransMedics Group, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TransMedics Group, Inc. EBITDA is ‪118.03 M‬ USD, and current EBITDA margin is 22.42%. See more stats in TransMedics Group, Inc. financial statements.
Like other stocks, TMDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TransMedics Group, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TransMedics Group, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TransMedics Group, Inc. stock shows the sell signal. See more of TransMedics Group, Inc. technicals for a more comprehensive analysis.